SEC Form 4 · accession 0001292445-16-000013
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W Breckon
Director
Period of report
Sep 26, 2016
Accepted (ET)
Sep 28, 2016 · 6:07 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Sep 26, 2016 | M | 7,600 | $8.45 | A | 15,561 | D | |
| Class A Common StockF2 | Sep 26, 2016 | S | 7,600 | $44.18 | D | 7,961 | D | |
| Class A Common Stock | Sep 26, 2016 | S | 38 | $44.61 | D | 7,923 | D | |
| Class A Common StockF3 | Sep 26, 2016 | S | 4,559 | $44.124 | D | 3,364 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F4 | $8.45 | Sep 26, 2016 | M | 7,600 | D | — | Sep 28, 2020 | Class A Common Stock | 7,600 | 0 | D |
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2016.
- F2The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.95 to $44.61, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F3The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.94 to $44.54, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F4The shares subject to this option vest yearly in five equal installments beginning on September 28, 2011, subject to continued service on the Issuer's Board of Directors.